BRII-B (02137) Schedules 19 March 2026 Board Meeting to Approve FY 2025 Annual Results

Bulletin Express03-09

Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.

The meeting’s agenda includes: 1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY 2025 results announcement. 3. Handling other routine corporate matters.

The board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.

The notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment